FAMOTIDINE 20 MG/2 ML VIAL

What it is

FAMOTIDINE 20 MG/2 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as famotidine.

FDA gives its dosage form as “injection” and “injection, solution” and its route as intravenous.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals and Fresenius Kabi USA, LLC.

FDA’s Established Pharmacologic Class for it is Histamine-2 Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.61 for 2 mL (2 × $0.30272 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 5 NDCs

• 00641-6022-25 · Hikma Pharmaceuticals USA Inc. · $0.30272 per ML · eff. 2026-09-23 filed
• 25021-0753-02 · Sagent Pharmaceuticals · $0.30272 per ML · eff. 2026-09-23 filed
• 63323-0739-12 · Fresenius Kabi USA, LLC · $0.30272 per ML · eff. 2026-09-23 filed
• 63323-0739-16 · Fresenius Kabi USA, LLC · $0.30272 per ML · eff. 2026-09-23 filed
• 67457-0433-22 · Mylan Institutional LLC · $0.30272 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

14 other products in the NADAC file share the FDA nonproprietary name famotidine with FAMOTIDINE 20 MG/2 ML VIAL.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J1308, for 2026-10-01 to 2026-12-31, comes to $0.72 for 2 mL, or $0.36 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0018 per 0.25 MG.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 2 mL? Is it lower than what I would pay through my insurance?
• How much is in the package I am getting? This page uses 2 mL; your package may hold a different amount.
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.